Data availability statement
The data that support the findings of this study are available upon request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
References
  1. Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464.
  2. Fujieda S, Imoto Y, Kato Y, et al. Eosinophilic chronic rhinosinusitis. Allergol Int. 2019;68:403-412.
  3. Zhang N, Van Zele T, Perez-Novo V, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol . 2008;122:961-968.
  4. Hulse KE, Stevens WW, Tan BK, et al. Pathogenesis of nasal polyposis.Clin Exp Allergy. 2015;45:328-346.
  5. Tokunaga T, Sakashita M, Haruna T, et al. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study.Allergy . 2015;70:995-1003.
  6. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology . 1993;31:183–184
  7. Sedaghat AR, Gray ST, Caradonna SD, et al. Clustering of chronic rhinosinusitis symptomatology reveals novel associations with objective clinical and demographic characteristics. Am J Rhinol Allergy. 2015 ;29:100-105.
  8. Shimizu T, Suzaki H. Past, present and future of macrolide thrapy for chronic rhinosinusitis in Japan. Auris Nasus Larynx . 2016:43:131-136.
  9. Schleimer RP. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol . 2017;12:331-57.
  10. Tojima I, Shimizu T. Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis. Curr Opin Allergy Clin Immunol.  19:18-25, 2019
  11. Tojima I, Kouzaki H, Shimizu S, et al. Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis. Clin Immunol. 2016; 170: 1-8.
  12. Tojima I, Matsumoto K, Kikuoka H, et al. Evidence for the induction of Th2 inflammation by group 2 innate lymphoid cells in response to prostaglandin D2 and cysteinyl leukotrienes in allergic rhinisits.Allergy. 2019; 74: 2417-26.
  13. Ho J, Bailey M, Zaunders J, et al. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin Exp Allergy. 2015;45:394-403.
  14. Walford HH, Lund SJ, Baum RE, et al. Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness. Clin Immunol.  2014; 155:126-135.
  15. Eastman JJ, Cavagnero KJ, Deconde AS, et al. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2017;140:101-108.e3.
  16. Winkler C, Hochdörfer T, Israelsson E, et al. Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients.J Allergy Clin Immunol. 2019;144:61-69.
  17. Zhong H, Fan XL, Yu QN, et al. Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis.Clinical Immunol. 2017; 183:293-299.
  18. Lao-Araya M, Steveling E, Scadding GW, et al. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. J Allergy Clin Immunol.2014;134(5):1193-1195.e4.
  19. Bartemes KR, Kephart GM, Fox SJ, et al. Enhanced innate type 2 immune response in peripheral blood from patients with asthma.J Allergy Clin Immunol.  2014; 134:671-678.
  20. Jia Y, Fang X, Zhu X, et al. IL-131 Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response. Am J Respir Cell Mol Biol . 2016;l 55:675-683.
  21. Liu T, Wu J, Zhao J, et al. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma. Respir Med. 2015;109:1391-1396.
  22. Poposki JA, Klingler AI, Tan BK, et al. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps. Immun Inflamm Dis. 2017;5:233-243.
  23. Bachert C, Marple B, Schlosser RJ, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020;6:86.
Table 1. Patient characteristics
Note: Data are presented as the mean ± SEM.
Abbreviations: eCRS, eosinophilic chronic rhinosinusitis; N-ERD, nonsteroidal anti-inflammatory drug-exacerbated respiratory disease; AR, allergic rhinitis; IgE, immunoglobulin E; JESREC, Japanese Epidemiological Survey of Refractory Eosinophilic Rhinosinusitis; pre-op, preoperative; LMK-CT score, Lund-Mackay computed tomography scan score; ILC2s, group 2 innate lymphoid cells; Lin, lineage; NPs, nasal polyps; PBMCs, peripheral blood mononuclear cells; post-op, postoperative; M, month.
Table 2. Postoperative treatments
Abbreviations: INCS, intranasal corticosteroid; SCS, systemic corticosteroid; NS, not significant.